Portfolio Companies News
March 21, 2019Orexo publishes the Annual Report f...
Uppsala, Sweden - March 21, 2019 – Orexo’s Annual Report, including the Sustainability Report, for the 2018 fiscal year has been published and can be downloaded on the company’s website, www.orexo.com (investors/reports, presentations and audiocasts). A PDF version is also attached to t... read more
March 21, 2019MIPS comments communication from Bo...
March 21, 2019Non-regulatory Due to the significant interest among investors and the impact on MIPS’ share price as a result of information in media about bike gear company Bontrager’s new helmets equipped with a new helmet technology called “WaveCel”, MIPS has elected to comment on... read more
March 20, 2019Pfizer secures exclusive option to ...
Pfizer and Vivet to collaborate on development of potential breakthrough therapy for Wilson disease Pfizer acquires 15% ownership stake in Vivet Paris, France and New York, US, March 20, 2019 – Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to devel... read more
March 19, 2019Altimmune Announces Positive Result...
Seroprotective HAI antibody response persisted more than one year after vaccination Company seeking partnership for further development and commercialization of NasoVAX GAITHERSBURG, Md., March 19, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics comp... read more
March 14, 2019Targovax grants Zelluna Immunothera...
Thursday, March 14, 2019 Targovax grants Zelluna an FTO license to Targovax patents and know-how to further enable development of Zelluna’s mutant RAS T-cell receptor therapies Targovax and Zelluna intend to collaborate on additional discovery and development of novel mutant RAS T ... read more
February 18, 2019Q4 2018 General Market Overview
Since the start in 1996, HealthCap funds have invested in 113 portfolio companies.
42 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.